Anticancer Bioscience

Biotechnology Research • Shuangliu, Sichuan, China • 11-20 Employees

Company overview

Headquarters	Jingxing Road, Biotown, 30°25'49.8"N 103°58'43.7"E, Chengdu, China 610000, CN
Website	anticancerbio.com
Keywords	Drug Discovery, Precision Oncology, Synthetic Lethality, MYC, Natural Product Library
Founded	2016
Employees	11-20
Socials

Key Contact at Anticancer Bioscience

Dun Yang

President and CEO

Anticancer Bioscience Email Formats

Anticancer Bioscience uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@anticancerbio.com), used 50% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@anticancerbio.com	50%
{first name}{last name}	johndoe@anticancerbio.com	30%
{last name}{last name}	doedoe@anticancerbio.com	20%

About Anticancer Bioscience

We are Anticancer Bioscience (ACB), Ltd., a growing precision therapeutics company headquartered in Chengdu, China, with global research and development teams in India, the United Kingdom, and the United States. The company is dedicated to the development of synthetic lethal therapies that address unmet medical needs. Our most advanced programs are synthetic lethal therapies for cancer. Genetic perturbations that fuel cancer growth can also introduce an over-dependence for the cancer cell on pathways and proteins that the normal, non-cancerous cell does not have. Anticancer Bioscience was founded by scientists that are experts in identifying and exploiting these cancer vulnerabilities. We have assembled a talented team of medicinal chemists and discovery scientists to tackle the opportunities we identify in the oncology space. It is our goal to advance safe, effective, and broad-spectrum targeted therapies for cancers that remain inaccessible or become refractory to existing therapy. For more information about our pipeline of innovative drugs, the four technology platforms that fuel our discovery process, partnering, and employment opportunities available with ACB, please visit www.anticancerbio.com. ACB is an equal opportunity employer committed to developing a safe and prosperous work environment.

Anticancer Bioscience revenue & valuation

Annual revenue	$1,283,325
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,200,000
Total funding	$10,600,000

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Vice President

C-Suite

Employees by Department

Anticancer Bioscience has 8 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Anticancer Bioscience's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-11-14	3	$10,600,000

Funding Insights

$10,600,000

Total funding amount

$10,600,000

Most recent funding amount

Number of funding rounds

Anticancer Bioscience Tech Stack

Discover the technologies and tools that power Anticancer Bioscience's digital infrastructure, from frameworks to analytics platforms.

Astra

WordPress themes

Underscore.js

JavaScript libraries

WP Job Openings

Recruitment & staffing

Google Maps

Maps

Animate.css

UI frameworks

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Google Tag Manager

Tag managers

Nginx

Reverse proxies

Frequently asked questions

Anticancer Bioscience is located in Shuangliu, Sichuan, CN.

Anticancer Bioscience was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Anticancer Bioscience has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Anticancer Bioscience has raised a total of $10,600,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Anticancer Bioscience

Dun Yang

President and CEO

4.8

40,000 users